市場調查報告書

全球細胞毒性藥委託製造市場:各生產規模、形狀、產品類型、地區 - 市場規模,佔有率,預測,及機會分析(2019年∼2027年)

Cytotoxic Drugs Contract Manufacturing Market, by Production Scale, by Form, by Product Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

出版商 Coherent Market Insights 商品編碼 920680
出版日期 內容資訊 英文 193 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球細胞毒性藥委託製造市場:各生產規模、形狀、產品類型、地區 - 市場規模,佔有率,預測,及機會分析(2019年∼2027年) Cytotoxic Drugs Contract Manufacturing Market, by Production Scale, by Form, by Product Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
出版日期: 2019年12月20日內容資訊: 英文 193 Pages
簡介

全球細胞毒性藥委託製造市場在過去10年大幅成長。由於癌症的發生率增加,主要企業的擴大,合作,收購等各種成長策略的採用增加,預計促進今後的市場成長。癌症治療的產品核可的增加,有推動市場成長的可能性。

本報告提供全球細胞毒性藥委託製造市場的相關調查,市場機會和趨勢,成長及阻礙因素,各生產規模、形狀、產品類型、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查目的、前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場範圍

  • 報告的說明
    • 市場定義、範圍
  • 摘要整理
    • 各生產規模
    • 各形狀
    • 各產品類型
    • 各地區
  • Coherent Opportunity Map (COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 流行病學
  • 市場趨勢
  • 產品的銷售
  • 法規方案
  • PEST分析
  • 合併、收購方案
  • 技術的進步

第4章 市場分析:各生產規模

  • 概要
  • 工業規模
  • 實驗規模
  • 實驗室規模

第5章 市場分析:各形狀

  • 概要
  • 液體
  • 固體

第6章 市場分析:各產品類型

  • 概要
  • 口服
  • 靜脈內

第7章 市場分析:各地區

  • 概要
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
    • Lonza Group
    • Piramal Group
    • Evonik Industries AG
    • Novasep Holding SAS
    • Merck KGaA (SAFC Pharma)
    • Baxter Biopharma Solutions
    • AbbVie Contract Manufacturing
    • Cambrex Corporation
    • CordenPharma International
    • BSP Pharmaceuticals S.p.A.
    • Catalent, Inc.
    • Albany Molecular Research Inc. (AMRI)
    • Evotec
    • WuXi AppTec Co., Ltd.
    • Pierre Fabre Laboratories
    • Dishman Group
  • 分析師的見解

第9章 Section

  • 參照資料
  • 調查方法
  • 關於本公司
目錄

Title:
Cytotoxic Drugs Contract Manufacturing Market, by Production Scale (Industrial Scale, Pilot Scale, and Laboratory Scale), by Form (Liquid, and Solid), by Product Type (Oral and Intravenous), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027.

Cytotoxic drugs contract manufacturing market has grown significantly over the last decade. Increasing incidence of cancer and increasing adoption of various growth strategies such as expansion, collaborations, and acquisitions by the key players are expected to boost market growth over the forecast period. Pharmaceutical and biotechnological companies are involved in research and development of cytotoxic drugs and high potency active pharmaceutical ingredients (HPAPIs), and in the manufacture of drugs in-house or outsource the production to other manufacturers.

Market Dynamics:

Rising incidence of cancer is expected to propel the market growth over the forecast period. For instance, according to an American Cancer Society estimations, 2017, 1,688,780 people were estimated to be diagnosed with cancer and 600,920 cancer deaths were reported in the U.S.

Increasing product approval for the treatment of cancer is expected to boost growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in October 2018, Catalent Pharma Solutions received the approval of U.S. Food and Drug Administration (FDA) for Verastem Oncology's COPIKTRA (duvelisib) capsules.

Furthermore, rising adoption of contract manufacturing services by the pharmaceutical companies is expected to drive growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in September 2018, GB Sciences, Inc. selected Catalent Pharma Solutions to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences' proprietary active pharmaceutical ingredients (APIs) for its Parkinson's disease therapies.

Key features of the study::

  • This report provides in-depth analysis of the cytotoxic drugs contract manufacturing market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2019 - 2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cytotoxic drugs contract manufacturing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as part of this study include Lonza Group, Piramal Group, Evonik Industries AG, Novasep Holding SAS, Merck KGaA (SAFC Pharma), Baxter Biopharma Solutions, AbbVie Contract Manufacturing, Cambrex Corporation, BSP Pharmaceuticals S.p.A., CordenPharma International, Catalent, Inc., Albany Molecular Research Inc., Evotec, WuXi AppTec Co., Ltd., Pierre Fabre Laboratories, and Dishman Group
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
  • The global cytotoxic drugs contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cytotoxic drugs contract manufacturing market

Detailed Segmentation::

  • Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale:
    • Industrial scale
    • Pilot Scale
    • Laboratory Scale
  • Global Cytotoxic Drugs Contract Manufacturing Market, By Form:
    • Liquid
    • Solid
  • Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type:
    • Oral
    • Intravenous
  • Global Cytotoxic Drugs Contract Manufacturing Market, By Region:
    • North America
      • By Production Scale:
      • Industrial scale
      • Pilot Scale
      • Laboratory Scale
      • By Form:
      • Liquid
      • Solid
      • By Product Type:
      • Oral
      • Intravenous
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Production Scale:
      • Industrial scale
      • Pilot Scale
      • Laboratory Scale
      • By Form:
      • Liquid
      • Solid
      • By Product Type:
      • Oral
      • Intravenous
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Production Scale:
      • Industrial scale
      • Pilot Scale
      • Laboratory Scale
      • By Form:
      • Liquid
      • Solid
      • By Product Type:
      • Oral
      • Intravenous
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Production Scale:
      • Industrial scale
      • Pilot Scale
      • Laboratory Scale
      • By Form:
      • Liquid
      • Solid
      • By Product Type:
      • Oral
      • Intravenous
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Production Scale:
      • Industrial scale
      • Pilot Scale
      • Laboratory Scale
      • By Form:
      • Liquid
      • Solid
      • By Product Type:
      • Oral
      • Intravenous
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Production Scale:
      • Industrial scale
      • Pilot Scale
      • Laboratory Scale
      • By Form:
      • Liquid
      • Solid
      • By Product Type:
      • Oral
      • Intravenous
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Lonza Group*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Piramal Group
    • Evonik Industries AG
    • Novasep Holding SAS
    • Merck KGaA (SAFC Pharma)
    • Baxter Biopharma Solutions
    • AbbVie Contract Manufacturing
    • Cambrex Corporation
    • BSP Pharmaceuticals S.p.A.
    • CordenPharma International
    • Catalent, Inc.
    • Albany Molecular Research Inc. (AMRI)
    • Evotec
    • WuXi AppTec Co., Ltd.
    • Pierre Fabre Laboratories
    • Dishman Group

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Production Scale
    • Market Snippet, By Form
    • Market Snippet, By Product Type
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Epidemiology
  • Market Trends
  • Product Launch
  • Regulatory Scenario
  • PEST Analysis
  • Merger and Acquisition Scenario
  • Technological Advancements

4. Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Industrial scale
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Pilot Scale
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Laboratory Scale
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

5. Global Cytotoxic Drugs Contract Manufacturing Market, By Form, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Liquid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Solid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Cytotoxic Drugs Contract Manufacturing Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Production Scale, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Form, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Production Scale, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Form, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Production Scale, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Form, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Production Scale, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Form, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Production Scale, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Form, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Production Scale, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Form, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Lonza Group
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Piramal Group
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Evonik Industries AG
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novasep Holding SAS
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck KGaA (SAFC Pharma)
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Baxter Biopharma Solutions
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Contract Manufacturing
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cambrex Corporation
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CordenPharma International
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BSP Pharmaceuticals S.p.A.
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Catalent, Inc.
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Albany Molecular Research Inc. (AMRI)
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Evotec
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • WuXi AppTec Co., Ltd.
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pierre Fabre Laboratories
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Dishman Group
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top